Arkadios Wealth Advisors
- SEC CIK
- 0001800798
- Latest filing
- Aug 10, 2026
CTXR holding history
Citius Pharmaceuticals, Inc. in every 13F filed by Arkadios Wealth Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CTXR overviewAll 13F holders of CTXRFull Q2 2026 holdings
- Shares (Q2 2026)
- 20,000
- Value
- $12.1K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 20,000 | $12.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 20,000 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 20,000 | $15.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 20,000 | $24.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 20,000 | $31.8K | <0.1% | +10,000+100.0% | Added | Holders |
| Q1 2025 | 10,000 | $14.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,000 | $40.0K | <0.1% | +2,000+25.0% | AddedConverted for a 1-for-25 split | Holders |
| Q3 2024 | 200,000 | $100.1K | <0.1% | +50,000+33.3% | Added | Holders |
| Q2 2024 | 150,000 | $87.6K | <0.1% | +50,000+50.0% | Added | Holders |
| Q1 2024 | 100,000 | $89.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 100,000 | $75.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 100,000 | $68.4K | <0.1% | +100,000 | New | Holders |